Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BENJAMIN POLLOCK

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1023351285
CMS profile
4209936
Location
MECHANICSBURG, PA

General Payments · PY2021–2023

$729.12

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2023

$173.42

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2023 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $173.42 15

By paying entity

PY2023 · sorted by reported total

Paying entityAmountRecords
Teva Pharmaceuticals USA, Inc. $173.42 15

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $163.82 20
PY2022 $391.88 26
PY2023 $173.42 15

Payment records · PY2023 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2023 20212022 Record-level detail is published for PY2023; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Teva Pharmaceuticals USA, Inc. $4.86 01/03/2023 Food and Beverage Undisputed 01/23/2026 1056796273 CMS
Teva Pharmaceuticals USA, Inc. $6.42 01/03/2023 Food and Beverage Undisputed 01/23/2026 1056796293 CMS
Teva Pharmaceuticals USA, Inc. $12.63 01/10/2023 Food and Beverage Undisputed 01/23/2026 1056796277 CMS
Teva Pharmaceuticals USA, Inc. $22.82 01/31/2023 Food and Beverage Undisputed 01/23/2026 1056796281 CMS
Teva Pharmaceuticals USA, Inc. $9.81 02/01/2023 Food and Beverage Undisputed 01/23/2026 1056796289 CMS
Teva Pharmaceuticals USA, Inc. $19.94 02/16/2023 Food and Beverage Undisputed 01/23/2026 1056796303 CMS
Teva Pharmaceuticals USA, Inc. $9.10 02/23/2023 Food and Beverage Undisputed 01/23/2026 1056796295 CMS
Teva Pharmaceuticals USA, Inc. $11.46 02/27/2023 Food and Beverage Undisputed 01/23/2026 1056796271 CMS
Teva Pharmaceuticals USA, Inc. $10.42 03/08/2023 Food and Beverage Undisputed 01/23/2026 1056796309 CMS
Teva Pharmaceuticals USA, Inc. $8.29 03/16/2023 Food and Beverage Undisputed 01/23/2026 1056796329 CMS
Teva Pharmaceuticals USA, Inc. $22.21 03/21/2023 Food and Beverage Undisputed 01/23/2026 1056796297 CMS
Teva Pharmaceuticals USA, Inc. $5.90 04/14/2023 Food and Beverage Undisputed 01/23/2026 1056796325 CMS
Teva Pharmaceuticals USA, Inc. $9.22 05/09/2023 Food and Beverage Undisputed 01/23/2026 1056796337 CMS
Teva Pharmaceuticals USA, Inc. $9.07 10/22/2023 Food and Beverage Undisputed 01/23/2026 1056796403 CMS
Teva Pharmaceuticals USA, Inc. $11.27 11/07/2023 Food and Beverage Undisputed 01/23/2026 1056796419 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023
Generated from
OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.